| LCD |
Effective
Date |
Revision
Effective
Date |
Title |
CPT Codes Covered in LCD |
|
L34149
|
10/01/2015
|
11/05/2023
|
Respiratory Care
|
|
|
L34163
|
10/01/2015
|
12/01/2019
|
Total Hip Arthroplasty
|
|
|
L34194
|
10/01/2015
|
10/01/2019
|
Blepharoplasty, Eyelid Surgery, and Brow Lift
|
|
|
L34203
|
10/01/2015
|
07/30/2023
|
Cataract Surgery in Adults
|
|
|
L34209
|
10/01/2015
|
12/01/2019
|
Treatment of Varicose Veins of the Lower Extremities
|
|
|
L34211
|
10/01/2015
|
04/01/2024
|
Trigger Point Injections (TPI)
|
|
|
L34213
|
10/01/2015
|
10/01/2019
|
Diagnostic and Therapeutic Colonoscopy
|
|
|
L34215
|
10/01/2015
|
04/08/2021
|
Lab: Flow Cytometry
|
|
|
L34218
|
10/01/2015
|
10/01/2019
|
Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
|
|
|
L34220
|
10/01/2015
|
08/18/2022
|
Lumbar MRI
|
|
|
L34228
|
10/01/2015
|
01/10/2021
|
Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
|
|
|
L34233
|
10/01/2015
|
10/01/2019
|
Benign Skin Lesion Removal (Excludes Actinic Keratosis, and Mohs)
|
|
|
L34314
|
10/01/2015
|
02/01/2020
|
Immune Globulin Intravenous (IVIg)
|
|
|
L34315
|
10/01/2015
|
10/01/2019
|
Electrocardiograms
|
|
|
L34324
|
10/01/2015
|
10/01/2019
|
Cardiovascular Stress Testing, Including Exercise and/or Pharmacological Stress and Stress Echocardiography
|
|
|
L34328
|
10/01/2015
|
12/01/2019
|
Peripheral Nerve Stimulation
|
|
|
L35136
|
10/01/2015
|
12/01/2019
|
Spinal Cord Stimulators for Chronic Pain
|
|
|
L35160
|
10/01/2015
|
05/04/2023
|
MolDX: Molecular Diagnostic Tests (MDT)
|
|
|
L35163
|
10/01/2015
|
10/01/2019
|
Plastic Surgery
|
|
|
L35170
|
10/01/2015
|
10/01/2019
|
Botulinum Toxin Types A and B Policy
|
|
|
L35456
|
10/01/2015
|
09/04/2022
|
Nerve Blockade for Treatment of Chronic Pain and Neuropathy
|
|
|
L35526
|
10/01/2015
|
10/01/2019
|
B-type Natriuretic Peptide (BNP) Testing
|
|
|
L35702
|
10/01/2015
|
12/01/2019
|
Mohs Micrographic Surgery
|
|
|
L36155
|
06/16/2016
|
07/20/2023
|
MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
|
|
|
L36180
|
04/19/2016
|
07/06/2023
|
MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
|
|
|
L36188
|
04/15/2016
|
10/14/2021
|
MolDX: MGMT Promoter Methylation Analysis
|
|
|
L36335
|
07/05/2016
|
07/27/2023
|
MolDX: NRAS Genetic Testing
|
|
|
L36351
|
10/15/2015
|
12/24/2020
|
Lab: Special Histochemical Stains and Immunohistochemical Stains
|
|
|
L36358
|
06/01/2016
|
03/21/2024
|
MolDX: Biomarkers in Cardiovascular Risk Assessment
|
|
|
L36380
|
05/03/2016
|
04/22/2021
|
MolDX: Breast Cancer Assay: Prosigna®
|
|
|
L36524
|
06/01/2016
|
12/01/2019
|
Nerve Conduction Studies and Electromyography
|
|
|
L36538
|
07/12/2016
|
11/01/2019
|
Treatment of Males with Low Testosterone
|
|
|
L36551
|
09/15/2016
|
07/08/2021
|
MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
|
|
|
L36575
|
09/07/2016
|
12/01/2019
|
Total Knee Arthroplasty
|
|
|
L36668
|
06/28/2016
|
10/08/2023
|
Urine Drug Testing
|
|
|
L36678
|
05/16/2017
|
03/04/2021
|
Lab: Bladder/Urothelial Tumor Markers
|
|
|
L36692
|
02/03/2017
|
12/01/2019
|
Vitamin D Assay Testing
|
|
|
L36702
|
03/13/2017
|
10/01/2019
|
Serum Magnesium
|
|
|
L36704
|
06/01/2017
|
12/30/2021
|
ProMark® Risk Score
|
|
|
L36846
|
07/21/2017
|
11/01/2019
|
Measurement of Salivary Hormones
|
|
|
L36861
|
06/05/2017
|
12/01/2019
|
Polysomnography and Other Sleep Studies
|
|
|
L36864
|
08/01/2017
|
03/04/2021
|
GlycoMark® Testing for Glycemic Control
|
|
|
L36941
|
03/27/2017
|
11/25/2021
|
MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
|
|
|
L37054
|
09/29/2017
|
04/28/2022
|
BDX-XL2
|
|
|
L37066
|
10/02/2017
|
02/25/2021
|
Lab: Coenzyme Q10 (CoQ10)
|
|
|
L37070
|
09/22/2017
|
06/30/2022
|
MolDX: DecisionDx-UM (Uveal Melanoma)
|
|
|
L37086
|
05/14/2018
|
08/20/2023
|
Transcranial Magnetic Stimulation (TMS)
|
|
|
L37295
|
01/30/2018
|
07/11/2021
|
MolDX: EndoPredict® Breast Cancer Gene Expression Test
|
|
|
L37299
|
01/30/2018
|
02/29/2024
|
MolDX: Prometheus® IBD sgi Diagnostic® Policy
|
|
|
L37373
|
10/08/2018
|
10/01/2019
|
MRI and CT Scans of the Head and Neck
|
|
|
L37502
|
02/18/2019
|
10/01/2019
|
Frequency of Hemodialysis
|
|
|
L37547
|
06/22/2018
|
11/01/2019
|
Chest X-Ray Policy
|
|
|
L37616
|
02/11/2019
|
06/09/2022
|
Lab: Cystatin C Measurement
|
|
|
L37620
|
06/03/2019
|
06/30/2022
|
MDS FISH
|
|
|
L37628
|
10/01/2018
|
02/25/2021
|
In Vitro Chemosensitivity & Chemoresistance Assays
|
|
|
L37729
|
04/01/2019
|
07/30/2023
|
Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease
|
|
|
L37750
|
02/10/2019
|
06/20/2024
|
MolDX: Melanoma Risk Stratification Molecular Testing
|
|
|
L37822
|
04/16/2019
|
10/28/2021
|
MolDX: Breast Cancer Index® (BCI) Gene Expression Test
|
|
|
L37887
|
05/27/2019
|
06/29/2023
|
MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
|
|
|
L37897
|
06/03/2019
|
10/14/2021
|
MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
|
|
|
L38119
|
05/17/2020
|
06/08/2023
|
MolDX: Next-Generation Sequencing for Solid Tumors
|
|
|
L38123
|
05/17/2020
|
03/28/2024
|
MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
|
|
|
L38151
|
06/07/2020
|
06/20/2024
|
MolDX: Pigmented Lesion Assay
|
|
|
L38299
|
03/23/2020
|
11/17/2024
|
Micro-Invasive Glaucoma Surgery (MIGS)
|
|
|
L38310
|
03/15/2020
|
03/15/2020
|
Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
|
|
|
L38327
|
08/24/2020
|
07/20/2023
|
MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
|
|
|
L38331
|
12/06/2020
|
05/23/2024
|
MolDX: Blood Product Molecular Antigen Typing
|
|
|
L38335
|
08/17/2020
|
08/24/2023
|
MolDX: Pharmacogenomics Testing
|
|
|
L38339
|
12/06/2020
|
07/25/2024
|
MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
|
|
|
L38351
|
08/03/2020
|
04/25/2024
|
MolDX: Repeat Germline Testing
|
|
|
L38613
|
04/26/2021
|
09/18/2022
|
Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
|
|
|
L38629
|
07/04/2021
|
|
MolDX: Molecular Testing for Solid Organ Allograft Rejection
|
|
|
L38643
|
07/04/2021
|
06/02/2022
|
MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
|
|
|
L38647
|
07/25/2021
|
08/06/2023
|
MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
|
|
|
L38657
|
11/02/2020
|
02/25/2024
|
Implantable Continuous Glucose Monitors (I-CGM)
|
|
|
L38705
|
12/27/2020
|
01/28/2024
|
Transurethral Waterjet Ablation of the Prostate
|
|
|
L38709
|
12/13/2020
|
|
Computed Tomography Cerebral Perfusion Analysis (CTP)
|
|
|
L38801
|
04/25/2021
|
07/07/2024
|
Facet Joint Interventions for Pain Management
|
|
|
L38814
|
01/02/2022
|
|
MolDX: Minimal Residual Disease Testing for Cancer
|
|
|
L38824
|
03/28/2021
|
12/19/2021
|
Colon Capsule Endoscopy (CCE)
|
|
|
L38902
|
11/28/2021
|
11/28/2021
|
Wound and Ulcer Care
|
|
|
L38972
|
08/08/2022
|
04/18/2024
|
MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
|
|
|
L39001
|
04/17/2022
|
06/02/2022
|
MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
|
|
|
L39005
|
08/08/2022
|
07/27/2023
|
MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
|
|
|
L39058
|
01/23/2022
|
01/23/2022
|
Platelet Rich Plasma Injections for Non-Wound Injections
|
|
|
L39116
|
11/12/2023
|
|
Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
|
|
|
L39230
|
12/26/2022
|
|
MolDX: Plasma-Based Genomic Profiling in Solid Tumors
|
|
|
L39240
|
06/19/2022
|
06/19/2022
|
Epidural Steroid Injections for Pain Management
|
|
|
L39262
|
05/28/2023
|
|
MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
|
|
|
L39373
|
08/06/2023
|
|
MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
|
|
|
L39396
|
03/05/2023
|
|
Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
|
|
|
L39462
|
03/19/2023
|
|
Sacroiliac Joint Injections and Procedures
|
|
|
L39467
|
10/15/2023
|
08/22/2024
|
MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
|
|
